Fig 1.
Schematic diagram of HCV disease progression among prisoners in Australia.
Each arrow represents the rate of change in the number of people in the population moving from one health state compartment to another health state compartment.
Fig 2.
Effect of length of stay (LOS) in prison (2 months LOS (a,b), 6 months LOS (c,d), 24 months LOS (e,f), 36 months LOS (g,h)) and treatment coverage (blue lines: 10% DAA, red lines: 25% DAA, orange lines: 50% DAA, purple lines: 90% DAA) on the incidence (per 100 py) and prevalence of chronic HCV in prison.
Table 1.
Estimated HCV-related outcomes with treatment scenarios and length of stay (best estimate).
Table 2.
Cost-effectiveness analysis of HCV treatment in prison, by length of stay and DAA treatment coverage, AUD 2015, mean (lower-upper).
Fig 3.
ICER plane for (a) 2 months, (b) 6 months, (c) 24 months, and (d) 36 months length of stay. Triangle shape represents 25% of people receive DAA, diamond shape represents 50% DAA, and cross shape represents 90% DAA.